RISK FACTORS AFFECTING THE EVENT OF BREAST CANCER IN SOUTHEAST ASIA
DOI:
https://doi.org/10.35730/jk.v11i0.692Keywords:
Breast Cancer, Breast Cancer Risk, Parity, Contraceptive, SmokingAbstract
Background: Breast cancer is one of the reproductive cancers that cause increased morbidity and mortality. Based on the Global Burden Cancer (Globocan) data, breast cancer has increased by more than 20%, while the mortality rate has increased by 14% since 2008.
Purpose: The aim of the study is to conclude a systematic literature review that is related to risk factors that influence breast cancer in Southeast Asia.
Methods: This study emphasizes risk factors that influence breast cancer incidence such as; contraceptive use, age, body mass index, menarche, menopause, parity, breastfeeding, and smoking using the systematic literature review method identified a total of 7 relevant journals and summarized in a narrative manner.
Result: The results of this journal review show that contrast use, age, body mass index (BMI) in this case a higher BMI or obesity, early age menarche that is influenced by unhealthy lifestyles, menopause, and the Human Papillomavirus (HPV) significant risk factors that influence breast cancer incidence in Southeast Asia.
Conclusion: Age, body mass index (BMI), and contraceptive use are very influential on the incidence of cancer.
References
J. Wang, H. Lv, Z. Xue, L. Wang, dan Z. Bai, “Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model,” BioMed research international, vol. 2018, hlm. 5307459, 2018, doi: 10.1155/2018/5307459.
J. K. Chahil dkk., “Genetic Polymorphisms Associated With Breast Cancer in Malaysian Cohort,” Indian Journal of Clinical Biochemistry, vol. 30, no. 2, hlm. 134–139, Apr 2015, doi: 10.1007/s12291-013-0414-0.
A. Poosari, S. Promthet, S. Kamsa-ard, K. Suwanrungruang, J. Longkul, dan S. Wiangnon, “Hormonal Contraceptive Use and Breast Cancer in Thai Women,” Journal of Epidemiology, vol. 24, no. 3, hlm. 216–220, 2014, doi: 10.2188/jea.JE20130121.
M. Wahidin, R. Djuwita, dan A. Adisasmita, “Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia,” Asian Pacific journal of cancer prevention : APJCP, vol. 19, no. 8, hlm. 2199–2203, 2018, doi: 10.22034/APJCP.2018.19.8.2199.
K. Ohba dkk., “In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction,” PLoS ONE, vol. 9, no. 5, hlm. 1–12, 2014, doi: 10.1371/journal.pone.0097787.
“Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews..”Int J Evid Based Healthc. 2015;13(3):141-6
“Economic.pdf.” Accessed: May 02, 2020. [Online]. Available on: https://nursing.lsuhsc.edu/JBI/docs/ReviewersManuals/Economic.pdf.
S. Mariapun, J. Li, C. H. Yip, N. A. M. Taib, dan S. H. Teo, “Ethnic differences in mammographic densities: An Asian cross-sectional study,” PLoS ONE, vol. 10, no. 2, hlm. 1–13, 2015, doi: 10.1371/journal.pone.0117568.
T. Anothaisintawee dkk., “Development and validation of a breast cancer risk prediction model for thai women: A cross-sectional study,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 16, hlm. 6811–6817, 2014, doi: 10.7314/APJCP.2014.15.16.6811.
M. M. Tan dkk., “A case-control study of breast cancer risk factors in 7,663 women in Malaysia,” PLoS ONE, vol. 13, no. 9, hlm. 1–12, 2018, doi: 10.1371/journal.pone.0203469.
S. Winters, C. Martin, D. Murphy, dan N. K. Shokar, “Breast Cancer Epidemiology, Prevention, and Screening,” Prog Mol Biol Transl Sci, vol. 151, hlm. 1–32, 2017, doi: 10.1016/bs.pmbts.2017.07.002.
Y.-S. Sun dkk., “Risk Factors and Preventions of Breast Cancer,” Int J Biol Sci, vol. 13, no. 11, hlm. 1387–1397, Nov 2017, doi: 10.7150/ijbs.21635.
K. Rojas dan A. Stuckey, “Breast Cancer Epidemiology and Risk Factors,” Clin Obstet Gynecol, vol. 59, no. 4, hlm. 651–672, 2016, doi: 10.1097/GRF.0000000000000239.
R. D. Nindrea, T. Aryandono, dan L. Lazuardi, “Breast Cancer Risk From Modifiable and Non-Modifiable Risk Factors among Women in Southeast Asia: A Meta-Analysis,” Asian Pac J Cancer Prev, vol. 18, no. 12, hlm. 3201–3206, 2017, doi: 10.22034/APJCP.2017.18.12.3201.
P. D. Y. Trieu, C. Mello-Thoms, J. K. Peat, T. D. Do, dan P. C. Brennan, “Risk Factors of Female Breast Cancer in Vietnam: A Case-Control Study,” Cancer Res Treat, vol. 49, no. 4, hlm. 990–1000, Okt 2017, doi: 10.4143/crt.2016.488.
B. Norsa’adah, B. N. Rusli, A. K. Imran, I. Naing, dan T. Winn, “Risk factors of breast cancer in women in Kelantan, Malaysia,” Singapore Med J, vol. 46, no. 12, hlm. 698–705, Des 2005.
A. Kouloura dkk., “HPV infection and breast cancer. Results of a microarray approach,” Breast, vol. 40, hlm. 165–169, Agu 2018, doi: 10.1016/j.breast.2018.05.010.
J. S. Lawson, B. Salmons, dan W. K. Glenn, “Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV),” Front Oncol, vol. 8, hlm. 1, 2018, doi: 10.3389/fonc.2018.00001.
S. De Carolis dkk., “HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles,” Front Oncol, vol. 9, hlm. 860, 2019, doi: 10.3389/fonc.2019.00860.
N. Khodabandehlou dkk., “Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins,” BMC Cancer, vol. 19, no. 1, hlm. 61, Jan 2019, doi: 10.1186/s12885-019-5286-0.
